Source link : https://www.newshealth.biz/health-news/novel-monoclonal-antibody-protects-infants-against-rsv/
The investigational monoclonal antibody clesrovimab protected against respiratory syncytial virus (RSV) disease and prevented RSV hospitalizations among healthy preterm- and term infants, according to results of a phase IIb/III study. A single dose of clesrovimab reduced the incidence of RSV-associated medically attended lower respiratory infections (MALRI) that had at least one indicator of LRI or […]
Author : News Health
Publish date : 2024-10-19 18:06:29
Copyright for syndicated content belongs to the linked Source.